UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 351

Sortiert nach

Treatment of older patients with HER2-positive metastatic breast cancer with pertuzumab, trastuzumab, and docetaxel: subgroup analyses from a randomized, double-blind, placebo-controlled phase III trial (CLEOPATRA)

Breast cancer research and treatment, 2013-11, Vol.142 (1), p.89-99

2013

Link zum Volltext

Verfügbarkeit prüfen

The trifunctional antibody catumaxomab for the treatment of malignant ascites due to epithelial cancer: Results of a prospective randomized phase II/III trial

International journal of cancer, 2010-11, Vol.127 (9), p.2209-2221

2010

Link zum Volltext

Verfügbarkeit prüfen

Cigarette smoking and lung cancer—relative risk estimates for the major histological types from a pooled analysis of case–control studies

International journal of cancer, 2012-09, Vol.131 (5), p.1210-1219

2012

Link zum Volltext

Verfügbarkeit prüfen

Efficacy and safety of ipilimumab monotherapy in patients with pretreated advanced melanoma: a multicenter single-arm phase II study

Annals of oncology, 2010-08, Vol.21 (8), p.1712-1717

2010

Link zum Volltext

Verfügbarkeit prüfen

A randomized phase II study of lapatinib + pazopanib versus lapatinib in patients with HER2+ inflammatory breast cancer

Breast cancer research and treatment, 2013, Vol.137 (2), p.471-482

2013

Link zum Volltext

Verfügbarkeit prüfen

Differences in human papillomavirus type distribution in high‐grade cervical intraepithelial neoplasia and invasive cervical cancer in Europe

International journal of cancer, 2013-02, Vol.132 (4), p.854-867

2013

Link zum Volltext

Verfügbarkeit prüfen

Phase 2 study of carlumab (CNTO 888), a human monoclonal antibody against CC-chemokine ligand 2 (CCL2), in metastatic castration-resistant prostate cancer

Investigational new drugs, 2013-06, Vol.31 (3), p.760-768

2013

Link zum Volltext

Verfügbarkeit prüfen

Sequential therapy for the locally advanced larynx and hypopharynx cancer subgroup in TAX 324: survival, surgery, and organ preservation

Annals of oncology, 2009-05, Vol.20 (5), p.921-927

2009

Link zum Volltext

Verfügbarkeit prüfen

Pilot study of oncological safety of extracorporeal shock wave therapy for post-mastectomy lymphedema in patients with breast cancer

Voprosy kurortologii, fizioterapii i lečebnoj fizičeskoj kulʹtury, 2022, Vol.99 (6), p.30

2022

Link zum Volltext

Verfügbarkeit prüfen

An open randomised trial of second-line endocrine therapy in advanced breast cancer: comparison of the aromatase inhibitors letrozole and anastrozole

European journal of cancer (1990), 2003-11, Vol.39 (16), p.2318-2327

2003

Link zum Volltext

Verfügbarkeit prüfen

Randomized Phase II, Double-Blind, Placebo-Controlled Study of Exemestane With or Without Entinostat in Postmenopausal Women With Locally Recurrent or Metastatic Estrogen Receptor-Positive Breast Cancer Progressing on Treatment With a Nonsteroidal Aromatase Inhibitor

Journal of clinical oncology, 2013-06, Vol.31 (17), p.2128-2135

2013

Link zum Volltext

Verfügbarkeit prüfen

A Prospective, Randomised EORTC Intergroup Phase 3 Study Comparing the Oncologic Outcome of Elective Nephron-Sparing Surgery and Radical Nephrectomy for Low-Stage Renal Cell Carcinoma

European urology, 2011-04, Vol.59 (4), p.543-552

2011

Link zum Volltext

Verfügbarkeit prüfen

Cigarette, Cigar, and Pipe Smoking and the Risk of Head and Neck Cancers: Pooled Analysis in the International Head and Neck Cancer Epidemiology Consortium

American journal of epidemiology, 2013-09, Vol.178 (5), p.679-690

2013

Link zum Volltext

Verfügbarkeit prüfen

Research-Based PAM50 Subtype Predictor Identifies Higher Responses and Improved Survival Outcomes in HER2-Positive Breast Cancer in the NOAH Study

Clinical cancer research, 2014-01, Vol.20 (2), p.511-521

2014

Link zum Volltext

Verfügbarkeit prüfen

Capecitabine/cisplatin versus 5-fluorouracil/cisplatin as first-line therapy in patients with advanced gastric cancer: a randomised phase III noninferiority trial

Annals of oncology, 2009-04, Vol.20 (4), p.666-673

2009

Link zum Volltext

Verfügbarkeit prüfen

Body mass index and risk of head and neck cancer in a pooled analysis of case–control studies in the International Head and Neck Cancer Epidemiology (INHANCE) Consortium

International journal of epidemiology, 2010-08, Vol.39 (4), p.1091-1102

2010

Link zum Volltext

Verfügbarkeit prüfen

Randomized Phase II Study of Erlotinib Plus Tivantinib Versus Erlotinib Plus Placebo in Previously Treated Non–Small-Cell Lung Cancer

Journal of clinical oncology, 2011-08, Vol.29 (24), p.3307-3315

2011

Link zum Volltext

Verfügbarkeit prüfen

Efficacy and safety results from OCTAVIA, a single-arm phase II study evaluating front-line bevacizumab, carboplatin and weekly paclitaxel for ovarian cancer

European journal of cancer (1990), 2013-12, Vol.49 (18), p.3831-3838

2013

Link zum Volltext

Verfügbarkeit prüfen

1 – 25 von 351

Suche als RSS-Feed

Aktive Filter

SpracheCroatian

SprachePersisch

SpracheRussisch

ThemaMiddle Aged

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(323)
Mit Volltextzugriff
(135)

Publikationsform

Artikel
(351)

Sprache

Englisch
(180)
Japanisch
(37)

Erscheinungsjahr

n.n

Thema

Humans
(351)
Female
(287)
Aged
(260)
Adult
(258)
Male
(220)
Life Sciences & Biomedicine
(143)
Science & Technology
(143)
Oncology
(99)
Treatment Outcome
(85)
Aged, 80 And Over
(70)
Neoplasm Staging
(61)
Antineoplastic Combined Chemotherapy Protocols - Therapeutic Use
(57)
Chemotherapy, Cancer, Regional Perfusion
(48)
Breast Cancer
(43)
Adolescent
(39)
Breast Neoplasms - Pathology
(36)
Risk Factors
(35)
Disease-Free Survival
(34)
Prognosis
(33)

14 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

5 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 90 Tagen
(1)

Menü

Weitere Dienste

Einstellungen

Lapatinib with trastuzumab for HER2-positive early breast cancer (NeoALTTO): a randomised, open-label, multicentre, phase 3 trial

Treatment of older patients with HER2-positive metastatic breast cancer with pertuzumab, trastuzumab, and docetaxel: subgroup analyses from a randomized, double-blind, placebo-controlled phase III trial (CLEOPATRA)

A phase III randomized comparison of lapatinib plus capecitabine versus capecitabine alone in women with advanced breast cancer that has progressed on trastuzumab: updated efficacy and biomarker analyses

The trifunctional antibody catumaxomab for the treatment of malignant ascites due to epithelial cancer: Results of a prospective randomized phase II/III trial

Cigarette smoking and lung cancer—relative risk estimates for the major histological types from a pooled analysis of case–control studies

Ramucirumab monotherapy for previously treated advanced gastric or gastro-oesophageal junction adenocarcinoma (REGARD): an international, randomised, multicentre, placebo-controlled, phase 3 trial

Efficacy and safety of ipilimumab monotherapy in patients with pretreated advanced melanoma: a multicenter single-arm phase II study

Neoadjuvant chemotherapy with trastuzumab followed by adjuvant trastuzumab versus neoadjuvant chemotherapy alone, in patients with HER2-positive locally advanced breast cancer (the NOAH trial): a randomised controlled superiority trial with a parallel HER2-negative cohort

A randomized phase II study of lapatinib + pazopanib versus lapatinib in patients with HER2+ inflammatory breast cancer

Differences in human papillomavirus type distribution in high‐grade cervical intraepithelial neoplasia and invasive cervical cancer in Europe

Sexual behaviours and the risk of head and neck cancers: a pooled analysis in the International Head and Neck Cancer Epidemiology (INHANCE) consortium

Randomized, Multicenter, Phase II Study of CO-101 Versus Gemcitabine in Patients With Metastatic Pancreatic Ductal Adenocarcinoma: Including a Prospective Evaluation of the Role of hENT1 in Gemcitabine or CO-101 Sensitivity

Phase 2 study of carlumab (CNTO 888), a human monoclonal antibody against CC-chemokine ligand 2 (CCL2), in metastatic castration-resistant prostate cancer

Sequential therapy for the locally advanced larynx and hypopharynx cancer subgroup in TAX 324: survival, surgery, and organ preservation

Pilot study of oncological safety of extracorporeal shock wave therapy for post-mastectomy lymphedema in patients with breast cancer

An open randomised trial of second-line endocrine therapy in advanced breast cancer: comparison of the aromatase inhibitors letrozole and anastrozole

Eribulin monotherapy versus treatment of physician's choice in patients with metastatic breast cancer (EMBRACE): a phase 3 open-label randomised study

Randomized Phase II, Double-Blind, Placebo-Controlled Study of Exemestane With or Without Entinostat in Postmenopausal Women With Locally Recurrent or Metastatic Estrogen Receptor-Positive Breast Cancer Progressing on Treatment With a Nonsteroidal Aromatase Inhibitor

A Prospective, Randomised EORTC Intergroup Phase 3 Study Comparing the Oncologic Outcome of Elective Nephron-Sparing Surgery and Radical Nephrectomy for Low-Stage Renal Cell Carcinoma

Cigarette, Cigar, and Pipe Smoking and the Risk of Head and Neck Cancers: Pooled Analysis in the International Head and Neck Cancer Epidemiology Consortium

Research-Based PAM50 Subtype Predictor Identifies Higher Responses and Improved Survival Outcomes in HER2-Positive Breast Cancer in the NOAH Study

Capecitabine/cisplatin versus 5-fluorouracil/cisplatin as first-line therapy in patients with advanced gastric cancer: a randomised phase III noninferiority trial

Body mass index and risk of head and neck cancer in a pooled analysis of case–control studies in the International Head and Neck Cancer Epidemiology (INHANCE) Consortium

Randomized Phase II Study of Erlotinib Plus Tivantinib Versus Erlotinib Plus Placebo in Previously Treated Non–Small-Cell Lung Cancer

Efficacy and safety results from OCTAVIA, a single-arm phase II study evaluating front-line bevacizumab, carboplatin and weekly paclitaxel for ovarian cancer

Aktive Filter

Suchergebnisse filtern